Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | AZN | AMGN | GILD | BMY |
| Company | Protagonist Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 103.72 | 204.75 | 345.45 | 139.24 | 59.12 |
| High | 104.00 | 204.75 | 348.17 | 140.71 | 59.63 |
| Low | 101.84 | 203.30 | 343.30 | 138.85 | 58.77 |
| Latest | 103.78 | 203.43 | 343.71 | 139.95 | 59.21 |
| Change | -0.32 | -0.06 | -4.23 | +0.24 | -1.89 |
| % Change | -0.31% | -0.03% | -1.22% | +0.17% | -3.09% |
| Volume | 102,256 | 404,507 | 802,949 | 770,250 | 1,556,113 |
| 20-Day Average Volume | 952,829 | 1,782,705 | 2,582,657 | 5,936,359 | 13,267,563 |
| Previous Close | 103.78 | 203.49 | 347.94 | 139.71 | 59.60 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 99.47 | 191.90 | 357.03 | 141.04 | 59.26 |
| 20-Day Raw Stochastic | 70.63% | 96.66% | 1.44% | 37.12% | 44.33% |
| 20-Day Relative Strength | 60.05 | 60.50 | 40.95 | 47.74 | 49.85 |
| Weighted Alpha | +111.84 | +53.05 | +19.95 | +34.04 | +22.80 |
| Today's Opinion | 100% Buy | 88% Buy | 24% Buy | 40% Buy | 64% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.84% since 03/27/26 | +8.27% since 03/27/26 | -1.42% since 03/27/26 | +4.01% since 03/27/26 | +0.80% since 03/27/26 |
| Low | 98.08 on 03/30/26 | 192.61 on 03/30/26 | 343.30 on 04/06/26 | 133.89 on 03/30/26 | 58.83 on 04/06/26 |
| High | 107.84 on 04/01/26 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +11.60% since 03/06/26 | +5.04% since 03/06/26 | -6.95% since 03/06/26 | -2.98% since 03/06/26 | -2.12% since 03/06/26 |
| Low | 90.58 on 03/18/26 | 182.39 on 03/24/26 | 343.30 on 04/06/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 107.84 on 04/01/26 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +24.92% since 01/06/26 | +7.42% since 01/06/26 | +4.14% since 01/06/26 | +15.06% since 01/06/26 | +8.43% since 01/06/26 |
| Low | 77.00 on 02/23/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 107.84 on 04/01/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +60.23% since 10/06/25 | +19.31% since 10/06/25 | +16.90% since 10/06/25 | +22.94% since 10/06/25 | +30.73% since 10/06/25 |
| Low | 62.24 on 10/07/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 112.82 on 10/07/25 | 42.52 on 10/29/25 |
| High | 107.84 on 04/01/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,622,097 | 315,594,272 | 187,563,328 | 173,411,136 | 121,687,400 |
| Shares Outstanding, K | 63,809 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 46,020,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -130,150,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 7,440,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -44,380,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.12 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.69 on 02/25/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.91 | 16.17 | 17.21 | 10.04 |